SG11201806589UA - Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes - Google Patents
Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymesInfo
- Publication number
- SG11201806589UA SG11201806589UA SG11201806589UA SG11201806589UA SG11201806589UA SG 11201806589U A SG11201806589U A SG 11201806589UA SG 11201806589U A SG11201806589U A SG 11201806589UA SG 11201806589U A SG11201806589U A SG 11201806589UA SG 11201806589U A SG11201806589U A SG 11201806589UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- gene expression
- aptamer
- street
- rule
- Prior art date
Links
- 108091023037 Aptamer Proteins 0.000 title abstract 5
- 230000014493 regulation of gene expression Effects 0.000 title abstract 3
- 108090000994 Catalytic RNA Proteins 0.000 title abstract 2
- 102000053642 Catalytic RNA Human genes 0.000 title abstract 2
- 108091092562 ribozyme Proteins 0.000 title abstract 2
- 230000001404 mediated effect Effects 0.000 title 1
- 230000014509 gene expression Effects 0.000 abstract 3
- 239000003446 ligand Substances 0.000 abstract 3
- 108020004422 Riboswitch Proteins 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- ZAZHPBXBNGWCDV-UHFFFAOYSA-N N2-Maltulosylarginine Chemical compound OC1C(O)C(CNC(CCCNC(=N)N)C(O)=O)(O)OCC1OC1C(O)C(O)C(O)C(CO)O1 ZAZHPBXBNGWCDV-UHFFFAOYSA-N 0.000 abstract 1
- 241000656145 Thyrsites atun Species 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3519—Fusion with another nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/52—Vector systems having a special element relevant for transcription encoding ribozyme for self-inactivation
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662290187P | 2016-02-02 | 2016-02-02 | |
| US201662290209P | 2016-02-02 | 2016-02-02 | |
| PCT/US2017/016303 WO2017136608A2 (en) | 2016-02-02 | 2017-02-02 | Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201806589UA true SG11201806589UA (en) | 2018-09-27 |
Family
ID=59500184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201806589UA SG11201806589UA (en) | 2016-02-02 | 2017-02-02 | Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US11512310B2 (de) |
| EP (1) | EP3411506B1 (de) |
| JP (1) | JP7222715B2 (de) |
| KR (1) | KR20180118650A (de) |
| CN (1) | CN109476697B (de) |
| AU (1) | AU2017213845B2 (de) |
| BR (1) | BR112018015815A2 (de) |
| CA (1) | CA3048625A1 (de) |
| DK (1) | DK3411506T3 (de) |
| ES (1) | ES2954929T3 (de) |
| FI (1) | FI3411506T3 (de) |
| HR (1) | HRP20231119T1 (de) |
| HU (1) | HUE063465T2 (de) |
| IL (1) | IL260842B2 (de) |
| LT (1) | LT3411506T (de) |
| MX (1) | MX2018009369A (de) |
| MY (1) | MY198399A (de) |
| PH (1) | PH12018501651A1 (de) |
| PL (1) | PL3411506T3 (de) |
| PT (1) | PT3411506T (de) |
| RS (1) | RS64585B1 (de) |
| SG (1) | SG11201806589UA (de) |
| SI (1) | SI3411506T1 (de) |
| WO (1) | WO2017136608A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7179744B2 (ja) * | 2017-03-02 | 2022-11-29 | メイラジーティーエックス・ユーケー・ザ・セカンド・リミテッド | アプタマー変調ＲＮａｓｅ Ｐ切断による遺伝子発現の調節 |
| WO2021191680A1 (en) | 2020-03-24 | 2021-09-30 | Meiragtx Uk Ii Limited | Aptamers that bind thiamine analogs and derivatives |
| JP2024504051A (ja) * | 2021-01-05 | 2024-01-30 | ユニヴァーシティ オブ ワシントン | モジュール式の動態学的に制御された機能性ｒｎａ構築物、並びに関連する組成物、システム、及び方法 |
| JP2024502620A (ja) * | 2021-01-11 | 2024-01-22 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | リボザイムで活性化されたｒｎａ構築物及びその使用 |
| WO2023131811A2 (en) | 2021-12-15 | 2023-07-13 | Meiragtx Uk Ii Limited | Polycistronic expression of gut peptides |
| WO2023111686A2 (en) * | 2021-12-15 | 2023-06-22 | Meiragtx Uk Ii Limited | Aptamers and small molecule ligands |
| CN114908095A (zh) * | 2022-06-09 | 2022-08-16 | 南开大学 | 一种基于核酶的靶向抑制靶标rna的方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050136035A1 (en) | 2003-06-03 | 2005-06-23 | Derek Ko | Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| ES2638274T3 (es) * | 2003-11-14 | 2017-10-19 | Children's Medical Center Corporation | Ribozimas de auto-escisión y usos de éstas |
| JP6336755B2 (ja) * | 2010-11-12 | 2018-06-06 | ザ ジェネラル ホスピタル コーポレイション | ポリコームに関連する非コードｒｎａ |
| US9222093B2 (en) * | 2011-06-30 | 2015-12-29 | The University Of Hong Kong | Two-way, portable riboswitch mediated gene expression control device |
-
2017
- 2017-02-02 DK DK17748194.2T patent/DK3411506T3/da active
- 2017-02-02 SG SG11201806589UA patent/SG11201806589UA/en unknown
- 2017-02-02 CN CN201780021411.0A patent/CN109476697B/zh active Active
- 2017-02-02 HU HUE17748194A patent/HUE063465T2/hu unknown
- 2017-02-02 SI SI201731412T patent/SI3411506T1/sl unknown
- 2017-02-02 AU AU2017213845A patent/AU2017213845B2/en active Active
- 2017-02-02 ES ES17748194T patent/ES2954929T3/es active Active
- 2017-02-02 LT LTEPPCT/US2017/016303T patent/LT3411506T/lt unknown
- 2017-02-02 MX MX2018009369A patent/MX2018009369A/es unknown
- 2017-02-02 WO PCT/US2017/016303 patent/WO2017136608A2/en active Application Filing
- 2017-02-02 US US16/074,681 patent/US11512310B2/en active Active
- 2017-02-02 JP JP2018559687A patent/JP7222715B2/ja active Active
- 2017-02-02 RS RS20230822A patent/RS64585B1/sr unknown
- 2017-02-02 PL PL17748194.2T patent/PL3411506T3/pl unknown
- 2017-02-02 FI FIEP17748194.2T patent/FI3411506T3/fi active
- 2017-02-02 MY MYPI2018001382A patent/MY198399A/en unknown
- 2017-02-02 CA CA3048625A patent/CA3048625A1/en active Pending
- 2017-02-02 BR BR112018015815A patent/BR112018015815A2/pt unknown
- 2017-02-02 KR KR1020187025104A patent/KR20180118650A/ko unknown
- 2017-02-02 EP EP17748194.2A patent/EP3411506B1/de active Active
- 2017-02-02 PT PT177481942T patent/PT3411506T/pt unknown
- 2017-02-02 HR HRP20231119TT patent/HRP20231119T1/hr unknown
-
2018
- 2018-07-29 IL IL260842A patent/IL260842B2/en unknown
- 2018-08-02 PH PH12018501651A patent/PH12018501651A1/en unknown
-
2022
- 2022-11-29 US US18/059,606 patent/US20230220382A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201806589UA (en) | Regulation of gene expression via aptamer-mediated control of self-cleaving ribozymes | |
| SG11201806496SA (en) | Antigen binding proteins that bind pd-l1 | |
| SG11201908719QA (en) | Biomarkers and car t cell therapies with enhanced efficacy | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201901899PA (en) | Bispecific trivalent antibodies binding to claudin6 or claudin18.2 and cd3 for treatment of claudin expressing cancer diseases | |
| SG11201808724SA (en) | Anti-tim-3 antibodies and compositions | |
| SG11201807021UA (en) | Heteroaryl inhibitors of pad4 | |
| SG11201811184UA (en) | Lag -3 binding members | |
| SG11201901528RA (en) | Proteolytically cleavable chimeric polypeptides and methods of use thereof | |
| SG11201810509PA (en) | Anti-pd-l1 antibodies | |
| SG11201805870YA (en) | Bispecific t cell engaging antibody constructs | |
| SG11201807176XA (en) | TGFß1-BINDING IMMUNOGLOBULINS AND USE THEREOF | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201811643TA (en) | Compounds and methods for modulating rna function | |
| SG11201805162VA (en) | Plasmid constructs for heterologous protein expression and methods of use | |
| SG11201406943XA (en) | Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof | |
| SG11201805514VA (en) | Processes for the preparation of 2,5-furandicarboxylic acid and intermediates and derivatives thereof | |
| SG11201403106SA (en) | Anti-phf-tau antibodies and their uses | |
| SG11201806605RA (en) | Regulation of gene expression through aptamer-modulated polyadenylation | |
| SG11201805052YA (en) | Therapeutic methods using erythrocytes | |
| SG11201407486PA (en) | Compositions and methods for modulating utrn expression | |
| SG11201804856VA (en) | C-terminal lysine conjugated immunoglobulins | |
| SG11201407483YA (en) | Compositions and methods for modulating smn gene family expression | |
| SG11201408228QA (en) | Dual receptor antagonistic antigen-binding proteins and uses thereof | |
| SG11201804668UA (en) | Bicyclic inhibitors of pad4 |